|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
11239948 |
005 |
20210426223745.4 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
150117s1997 kyu ob 001 0 eng d |
010 |
|
|
|a 96016767
|
019 |
|
|
|a 900085979
|a 1055334493
|a 1066451388
|a 1081190587
|
020 |
|
|
|a 9780813159065
|q (electronic bk.)
|
020 |
|
|
|a 0813159067
|q (electronic bk.)
|
020 |
|
|
|z 9780813119441
|
020 |
|
|
|a 0813119448
|q (cloth : alk. paper)
|
020 |
|
|
|a 9780813119441
|
035 |
|
|
|a (OCoLC)900344514
|z (OCoLC)900085979
|z (OCoLC)1055334493
|z (OCoLC)1066451388
|z (OCoLC)1081190587
|
035 |
|
9 |
|a (OCLCCM-CC)900344514
|
037 |
|
|
|a 22573/ctt129cn3d
|b JSTOR
|
040 |
|
|
|a EBLCP
|b eng
|e rda
|e pn
|c EBLCP
|d N$T
|d OCLCQ
|d HEBIS
|d N$T
|d E7B
|d KUK
|d IDEBK
|d KUK
|d OCLCF
|d JSTOR
|d YDXCP
|d D6H
|d AGLDB
|d MOR
|d CCO
|d PIFAG
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d IOG
|d U3W
|d EZ9
|d STF
|d OCLCQ
|d VTS
|d ICG
|d VT2
|d AU@
|d REC
|d OCLCQ
|d WYU
|d LVT
|d TKN
|d OCLCO
|d DKC
|d OCLCQ
|d OCLCO
|d M8D
|d OCLCA
|
049 |
|
|
|a MAIN
|
050 |
|
4 |
|a RC78.7.N83
|
060 |
1 |
0 |
|a WN 185 C759 1996
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
072 |
|
7 |
|a MED081000
|2 bisacsh
|
072 |
|
7 |
|a TEC015000
|2 bisacsh
|
245 |
0 |
0 |
|a Contrast-enhanced clinical magnetic resonance imaging /
|c Val M. Runge, editor.
|
264 |
|
1 |
|a Lexington :
|b University Press of Kentucky,
|c 1997.
|
300 |
|
|
|a 1 online resource (196 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover; Half-title; Title; Copyright; Dedication; Contents; Preface; Contributors; Chapter 1 Principles of MR Contrast; Introduction; Contrast Agent Design Requirements; MR Contrast Mechanisms; Relaxivity Theory; Clinical Applications; Conclusion; References; Chapter 2 Brain: Neopiastic Disease; Introduction; Normal Enhancement Patterns; Primary Intracranial Neoplasms; Astrocytoma/Glioblastoma; Oligodendroglioma; Ganglion Cell Tumors; Brainstem Gliomas; Ependymoma/Subependymoma; Medulloblastoma/PNET; Lymphoma; Choroid Plexus Papilloma; Acoustic Neuroma; Hemangioblastoma; Meningioma.
|
505 |
8 |
|
|a CraniopharyngiomaColloid Cyst; Arachnoid Cyst; Pineal Cyst; Germ Cell Tumors; Miscellaneous Pineal Tumors; Epidermoid/Dermoid; Metastatic Disease; Bony Lesions; Clivus Chordoma; Calvarial/Dural Metastases; Neurophakomatoses; Neurofibromatosis Type 1 (von Recklinghausen 'sDisease); Neurofibromatosis Type 2; Tuberous Sclerosis; The Post-Therapy Patient; Conclusion; References; Chapter 3 Brain: Non-Neoplastic Disease; Introduction; Infection; Vascular disorders; Diseases of white matter; Trauma; Conclusion; References; Chapter 4 Spine: Neopiastic and Non-Neoplatic Disease; Introduction.
|
505 |
8 |
|
|a General Principles of MR Contrast UseDifferential Diagnosis of Pathologic Spinal Enhancement; Applications of MR Contrast Use; Hereditary and Developmental Disease; Degenerative Disease; Infection; Vascular Disease; Neoplastic Disease; Demyelinating Disease; Conclusion; References; Chapter 5 Body Applications; Introduction; Contrast Media; Imaging Technique; Head and Neck; Lung; Heart; Breast; Liver and Spleen; Bowel; Kidney; Adrenal Glands; Pelvis; Musculoskeletal System; Conclusion; References; Chapter 6 Safety, New Applications, and New MR Agents; Introduction; Design Requirements.
|
505 |
8 |
|
|a Gadolinium ChelatesGd DTPA; Gd DTPA-BMA; Gd HP-DO3A; Other Compounds; Special Applications; High Dose; Magnetization Transfer; MR Angiography; First Pass Studies; Dysprosium Chelates; Liver Agents; Gd BOPTA; Gd EOB-DTPA; Mn DPDP; Paniculate Compounds; Oral Contrast Media; Gadolinium Chelates; Manganese Based Agents; Paniculate Agents; Conclusion; References; Index.
|
520 |
|
|
|a In Contrast-Enhanced Clinical Magnetic Resonance Imaging , Val M. Runge and other leading experts present an overview of the basic principles regarding MR contrast media, a review of clinical applications in the head, spine, and body, and a look at future developments. Their focus is on clinical applications, with extensive illustrations to demonstrate the use of MR in each anatomic area and to aid in film interpretation.
|
650 |
|
0 |
|a Magnetic resonance imaging.
|0 http://id.loc.gov/authorities/subjects/sh85079741
|
650 |
|
0 |
|a Contrast-enhanced magnetic resonance imaging.
|0 http://id.loc.gov/authorities/subjects/sh2007006223
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Reference.
|2 bisacsh
|
650 |
|
7 |
|a Contrast-enhanced magnetic resonance imaging.
|2 fast
|0 (OCoLC)fst01743788
|
650 |
|
7 |
|a Magnetic resonance imaging.
|2 fast
|0 (OCoLC)fst01005780
|
650 |
1 |
2 |
|a Magnetic Resonance Imaging
|x methods.
|
650 |
2 |
2 |
|a Contrast-enhanced magnetic resonance imaging.
|
650 |
2 |
2 |
|a Neoplasms
|x diagnosis.
|
655 |
|
4 |
|a Electronic books.
|
655 |
|
0 |
|a Electronic books.
|
700 |
1 |
|
|a Runge, Val M.
|0 http://id.loc.gov/authorities/names/n86044732
|
776 |
0 |
8 |
|i Print version:
|a Runge, Val M.
|t Contrast-Enhanced Clinical Magnetic Resonance Imaging.
|d Lexington : The University Press of Kentucky, ©2015
|z 9780813119441
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a oclccm
|
999 |
f |
f |
|i 40125dc3-7464-5a95-9f39-adb4e788490b
|s 465655b9-ef1d-5798-8594-efffe95552de
|
928 |
|
|
|t Library of Congress classification
|a RC78.7.N83
|l Online
|c UC-FullText
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=938248
|z eBooks on EBSCOhost
|g ebooks
|i 12420675
|